Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 5 of 5
-
ItemInitial investigation of the efficacy and biosafety of sodium hyaluronate (healon) as an aid to electrode array insertion( 1995)Stimulation of residual neural elements by electrodes inserted into the cochlea to produce the perception of speech and environmental sounds in profoundly deaf people is a fundamental aim of cochlear implantation. The multiple-channel cochlear implant utilizes the tonotopic arrangement of the organ of Corti to also achieve place pitch perception by stimulating different electrode bands. It may be possible to improve the range of pitches perceived by present cochlear implant patients by inserting the electrode array more deeply. To help achieve this, investigators have used sodium hyaluronate as a lubricant for electrode insertions. 1 It was felt deeper insertions were produced with sodium hyaluronate. Before introducing this substance as part of the surgical protocol for the Melbourne Cochlear Implant Clinic, it was decided to investigate its efficacy in aiding deeper insertions of the electrode. In addition, it was also necessary to determine if sodium hyaluronate, in conjunction with cochlear implantation, had adverse effects on the inner ear. This study was undertaken to address these issues.
-
ItemVowel imitation task: results over time for 28 cochlear implant children under the age of eight years( 1995)With increasing numbers of implanted children under the age of 4 years, numerous researchers have reminded us of the need for valid, sensitive, and reliable tests of developing speech perception.1,2 In addition to studies of the efficacy of implanted prostheses, there is a need to investigate the many variables that influence children's communicative performance, such as changes in speech-coding strategy, updated speech-processing systems, the effects of various training regimens, and the selection of educational and communication modes.
-
ItemSpeech perception in children using the advanced Speak speech-processing strategy( 1995)The Speak speech-processing strategy, developed by the University of Melbourne and commercialized by Cochlear Pty Limited for use in the new Spectra 22 speech processor, has been shown to provide improved speech perception for adults in both quiet and noisy situations. The present study evaluated the ability of children experienced in the use of the Multipeak (Mpeak) speech-processing strategy (implemented in the Nucleus Minisystem-22 cochlear implant) to adapt to and benefit from the advanced Speak speech-processing strategy (implemented in the Nucleus Spectra 22 speech processor). Twelve children were assessed using Mpeak and Speak over a period of 8 months. All of the children had over 1 year's previous experience with Mpeak, and all were able to score significantly on open-set word and sentence tests using the cochlear implant alone. Children were assessed with both live-voice and recorded speech materials, including Consonant-Nucleus-Consonant monosyllabic words and Speech Intelligibility Test sentences. Assessments were made in both quiet and in noise. Assessments were made at 3-week intervals to investigate the ability of the children to adapt to the new speech-processing strategy. For most of the children, a significant advantage was evident when using the Speak strategy as compared with Mpeak. For 4 of the children, there was no decrement in speech perception scores immediately following fitting with Speak. Eight of the children showed a small (10% to 20%) decrement in speech perception scores for between 3 and 6 weeks following the changeover to Speak. After 24 weeks' experience with Speak, 11 of the children had shown a steady increase in speech perception scores, with final Speak scores higher than for Mpeak. Only 1 child showed a significant decrement in speech perception with Speak, which did not recover to original Mpeak levels.
-
ItemCochlear implantation: osteoneogenesis, electrode-tissue impedance, and residual hearing( 1995)This study was undertaken to find out how new bone is produced in the implanted cochlea, and the effects of fibrous tissue and new bone growth on electrode-tissue impedance. This knowledge is essential, as bone and fibrous tissue in the cochlea could account for variations in patients' speech perception performance. The study was also carried out to examine the effects of implantation on residual hearing. This information is also important, as cochlear implant speech perception results in profoundly deaf people are now better on average than severely or profoundly deaf people obtain with a hearing aid. Consequently, more people will need to be considered for cochlear implantation in ears with some residual hearing. In this case we need to know to what extent residual hearing is affected by implantation. (From Introduction)
-
ItemA new portable sound processor for the University of Melbourne/ Nucleus Limited multielectrode cochlear implant( 1992)Abstract not available due to copyright.